http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F 2026-04-27T14:11:23Z 本wiki的该页面的版本历史 MediaWiki 1.30.0 http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=1601306&oldid=prev 2024-07-06T14:00:00Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=1601307&oldid=prev 2024-07-06T12:25:57Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 12:25的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=1097529&oldid=prev 2024-07-05T14:20:35Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月5日 (五) 14:20的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

KGadmin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=1097528&oldid=prev 2022-09-22T13:56:59Z

<p>修改1</p> <table class="diff diff-contentalign-left" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="2" style="background-color: white; color:black; text-align: center;">2022年9月22日 (四) 13:56的版本</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l13" >第13行：</td> <td colspan="2" class="diff-lineno">第13行：</td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>结果:[[乳腺癌]]组TSGF、CA153、[[CEA含量]]均高于乳腺良性疾病组,两组差异有统计学意义(P<del class="diffchange diffchange-inline">&lt;</del>0.05).</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>结果:[[乳腺癌]]组TSGF、CA153、[[CEA含量]]均高于乳腺良性疾病组,两组差异有统计学意义(P<ins class="diffchange diffchange-inline">&amp;amp;lt;</ins>0.05).</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===时间分辨荧光免疫分析法检测乳腺疾病患者血清CA15-3、CEA的临床意义（中华医学会文献）===</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===时间分辨荧光免疫分析法检测乳腺疾病患者血清CA15-3、CEA的临床意义（中华医学会文献）===</div></td></tr> <tr><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结果:血清CA15-3、[[CEA含量]],正常对照组、乳腺增生组、乳腺良性肿瘤组3组间比较差异均无显著性(P＞0.05),但[[乳腺癌]]无复发或无转移组含量均明显高于前3组(P＜0.05),[[乳腺癌]]有复发或转移组术前均明显高于前3组(P＜0.01)及[[乳腺癌]]无复发或无转移</div></td><td class='diff-marker'>&#160;</td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>结果:血清CA15-3、[[CEA含量]],正常对照组、乳腺增生组、乳腺良性肿瘤组3组间比较差异均无显著性(P＞0.05),但[[乳腺癌]]无复发或无转移组含量均明显高于前3组(P＜0.05),[[乳腺癌]]有复发或转移组术前均明显高于前3组(P＜0.01)及[[乳腺癌]]无复发或无转移</div></td></tr> </table>

Admin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=537696&oldid=prev 2021-11-22T13:11:23Z

<p>导入1个版本</p> <table class="diff diff-contentalign-left" data-mw="interface"> <tr style="vertical-align: top;" lang="zh-CN"> <td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td> <td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月22日 (一) 13:11的版本</td> </tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div> </td></tr></table>

Admin http://120.24.161.253:5617/index.php?title=%E4%B9%B3%E8%85%BA%E7%99%8C-%E5%AE%9E%E9%AA%8C%E5%AE%A4%E6%A3%80%E6%9F%A5-CEA%E5%90%AB%E9%87%8F&diff=537695&oldid=prev 2021-10-19T13:56:59Z

<p>修改1</p> <p><b>新页面</b></p><div>主实体：[[乳腺癌]]，关系：[[实验室检查]] ，尾实体：[[CEA含量]]<br /> <br /> 实体ID:''216275''<br /> ==关系介绍==<br /> 待补充<br /> <br /> ==来源==<br /> ===血清CA153、CA125和CEA联合检测在乳腺癌临床诊疗中的应用（中华医学会文献）===<br /> 结果 [[乳腺癌]]组患者血清CA153、CA125和[[CEA含量]]均明显高于良性疾病组和正常对照组,差异具有统计学意义(P＜0.01)；良性疾病组患者血清CA153、CA 125和[[CEA含量]]与正常对照组比较差异无显著性(P＞0.05).<br /> <br /> ===乳腺癌手术前后血清CA153、CA125、CEA检测的临床意义（中华医学会文献）===<br /> 结论:检测[[乳腺癌]]患者血清CA153、CA125和[[CEA含量]]对临床诊断和预后观察具有重要的临床价值.<br /> <br /> ===血清TSGF、CA153、CA125及CEA联合检测对乳腺癌的诊断价值（中华医学会文献）===<br /> 结果:[[乳腺癌]]组TSGF、CA153、[[CEA含量]]均高于乳腺良性疾病组,两组差异有统计学意义(P&lt;0.05).<br /> <br /> ===时间分辨荧光免疫分析法检测乳腺疾病患者血清CA15-3、CEA的临床意义（中华医学会文献）===<br /> 结果:血清CA15-3、[[CEA含量]],正常对照组、乳腺增生组、乳腺良性肿瘤组3组间比较差异均无显著性(P＞0.05),但[[乳腺癌]]无复发或无转移组含量均明显高于前3组(P＜0.05),[[乳腺癌]]有复发或转移组术前均明显高于前3组(P＜0.01)及[[乳腺癌]]无复发或无转移</div>

Admin